Florfenicol, Flunixin

Verify with FDA CVM →

147 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
147
Total Reports
105
Deaths Reported
7140.0%
Death Rate

Active Ingredients

Florfenicol, Flunixin

Administration Routes

SubcutaneousUnknownTopicalOphthalmicIntramuscular

Species Affected

Cattle 116
Human 15
Unknown 12
Goat 2
Sheep 2

Most Affected Breeds

Holstein-Friesian also known as Holstein 62
Unknown 27
Crossbred Bovine/Cattle 24
Cattle (unknown) 19
Aberdeen Angus 7
Sheep (unknown) 2
Pygmy 1
Jersey 1
Goat (unknown) 1
Mixed (Cattle) 1

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 66
Death 59
DEATH-TREATMENT FAILURE 42
CULTURE/TITER DATA ABNORMAL 39
PR-LUNG(S), LESION(S) 31
Unclassifiable adverse event 23
PR-GI, LESION(S) 16
Accidental exposure 14
PR-LIVER, LESION(S) 14
PR-SPLEEN, LESION(S) 14
PR-THYMUS, LESION(S) 8
PR-KIDNEY(S), LESION(S) 8

Outcome Breakdown

Died
105 (97.2%)
Outcome Unknown
1 (0.9%)
Ongoing
1 (0.9%)
Recovered/Normal
1 (0.9%)

Data Summary

Metric Value
Total adverse event reports 147
Reports involving death 105
Case-fatality rate (reported events) 7140.0%
Distinct species in reports 5
Distinct breeds in reports 12
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Florfenicol, Flunixin Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 147 adverse event reports referencing Florfenicol, Flunixin, including 105 reports in which the animal died — a 7140.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Florfenicol, Flunixin. Reported administration routes include Subcutaneous, Unknown, Topical, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Florfenicol, Flunixin reports are Cattle (116 reports), Human (15 reports), Unknown (12 reports), with Cattle accounting for the largest share. Within those species, Holstein-Friesian also known as Holstein (62), Unknown (27), Crossbred Bovine/Cattle (24) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Florfenicol, Flunixin are Lack of efficacy (bacteria) - NOS (66), Death (59), DEATH-TREATMENT FAILURE (42), CULTURE/TITER DATA ABNORMAL (39). Of the 108 reports with a coded outcome, Died is the leading category at 97.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Florfenicol, Flunixin.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial